Live Breaking News & Updates on Tycel phillips

Stay updated with breaking news from Tycel phillips. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

City of Hope to Unveil New Cancer Treatments at 2024 ASCO Meeting

City of Hope to Unveil New Cancer Treatments at 2024 ASCO Meeting
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Chicago , Illinois , Antelope-valley , Brazil , Brazilian , Sumanta-kumar-pal , Tanyanika-phillips , William-dale , Daniel-schmolze , Sumanta-monty-pal

City of Hope Shares Promising Stem Cell and Blood Cancer Data at ASCO 2024

City of Hope Shares Promising Stem Cell and Blood Cancer Data at ASCO 2024
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United-states , Chicago , Illinois , William-dale , Daniel-schmolze , Sumanta-kumar-pal , Tycel-phillips , Marwang-fakih , Richardt-lee , Tanyanika-phillips , Monzrm-al-malki , Cristiane-decat-bergerot

Dr Phillips on the Rationale for the GLOBRYTE Trial in Relapsed/Refractory MCL

Tycel Phillips, MD, discusses the rationale for launching the phase 3 GLOBRYTE trial evaluating glofitamab monotherapy in patients with relapsed/refractory mantle cell lymphoma, highlighting ongoing enrollment efforts.

Spain , China , France , Sweden , United-kingdom , Australia , Taiwan , Italy , United-states , Brazil , South-korea , Canada

Dr Phillips on the Evolving Treatment Landscape in MCL

Tycel Phillips, MD, discusses current and emerging therapeutic treatment strategies for patients with mantle cell lymphoma.

Tycel-phillips , Division-of-lymphoma , Department-of-hematology-hematopoietic-cell-transplantation , Hematopoietic-cell-transplantation , D , City-of-hope , Patients-with-mantle-cell-lymphoma ,

Experts Highlight Their Biggest Takeaways from the 2023 SOHO Annual Meeting

Experts Highlight Their Biggest Takeaways from the 2023 SOHO Annual Meeting
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Houston , Texas , United-states , Yi-lin , Tycel-phillips , Stephenm-ansell , Harry-erba , Department-of-medicine , Department-of-oncology , Division-of-lymphoma , Philips , Leukemia-program

Dr Phillips on the Use of Bispecific Antibodies and CAR T-Cell Therapy in MCL and FL

Tycel Phillips, MD, MPH, discusses the use of bispecific antibodies and CAR T-cell therapy across hematologic malignancies, including in patients with mantle cell lymphoma and follicular lymphoma.

Texas , United-states , Tycel-phillips , University-of-texas-md-anderson-cancer-center , Department-of-hematology-hematopoietic-cell-transplantation , Division-of-lymphoma , Hematopoietic-cell-transplantation , Cancer-center , City-of-hope , Mantle-cell-lymphoma- , Onclive-tv , Mcl

Dr Phillips on Treatment With Bispecific Antibodies and CAR T-Cell Therapy in MCL

Dr Phillips on Treatment With Bispecific Antibodies and CAR T-Cell Therapy in MCL
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Tycel-phillips , Department-of-hematology-hematopoietic-cell-transplantation , Division-of-lymphoma , Hematopoietic-cell-transplantation ,

Dr Phillips on the Evaluation of Frontline Treatment With Acalabrutinib Plus BR in MCL

Tycel Phillips, MD, MPH, discusses the ongoing phase 3 ECHO trial of acalabrutinib plus bendamustine and rituximab in the front line for patients with mantle cell lymphoma.

Tycel-phillips , Department-of-hematology-hematopoietic-cell-transplantation , Division-of-lymphoma , Hematopoietic-cell-transplantation , City-of-hope , Onclive-tv , Mantle-cell-lymphoma- , Calquence , Acalabrutinib , Bendamustine , Rituximab , Rituxan

Phase 1b Data Support Continued Investigation of Acalabrutinib Plus BR in MCL

Tycel Phillips, MD, discusses the rationale and design of a phase 1b trial investigating acalabrutinib plus bendamustine and rituximab in patients with mantle cell lymphoma, highlights key efficacy and safety findings in the treatment-naïve and relapsed/refractory patient cohorts, and postulated next steps on the horizon for investigating BTK inhibitors in combination with chemotherapy in this patient population.

California , United-states , Tycel-phillips , Division-of-lymphoma , Department-of-hematology , Hematopoietic-cell-transplantation , Bendamustine , Acalabrutinib , Rituximab , D , Nct02717624 , Mantle-cell-lymphoma

Dr Phillips on the Preliminary Efficacy of Acalabrutinib Plus BR in MCL

Tycel Phillips, MD, MPH, discusses the updated safety profile and clinical activity seen with the addition of acalabrutinib to bendamustine and rituximab in patients with mantle cell lymphoma.

Tycel-phillips , Division-of-lymphoma , Department-of-hematology-hematopoietic-cell-transplantation , Hematopoietic-cell-transplantation ,